Kodiak Sciences
KOD
91.08
-1.26
-1.36%
Kodiak Sciences
US · KOD
#1934 by market cap
Listed 2018
91.08
-1.26
-1.36%
Live - 5344 symbols - heartbeat 31s ago
· 2026-10-08 08:34
Pre-market
90.52
-0.61%
After-hours
91.08
0.00%
Overnight
90.38
-0.77%
- Market cap
- 5.72B
- P/E (TTM)i
- -21.74
- P/Bi
- 93.70
- EPSi
- -4.32
- Div yieldi
- 0.00%
- 52W posi
- 86%
Reader sentiment
Are you bullish or bearish on KOD?
Anonymous reader poll. Unscientific, not investment advice.
Revenue annual, last 8 years
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | 7.58M | 11.68M | 28.62M | 49.71M | 73.79M | 71.02M | 60.75M | 52.02M |
| Research & development | 18.79M | 37.51M | 107.39M | 217.34M | 267.59M | 206.30M | 126.10M | 182.37M |
| Operating profit | -26.37M | -49.19M | -136.01M | -267.05M | -341.38M | -277.32M | -186.85M | -234.39M |
| Pretax profit | -41.44M | -47.37M | -133.10M | -266.99M | -333.82M | -260.49M | -176.21M | -229.97M |
| Tax | -- | -- | -- | -- | -- | -- | -- | -- |
| Net profit | -41.44M | -47.37M | -133.10M | -266.99M | -333.82M | -260.49M | -176.21M | -229.97M |
| Basic EPS | -3 | -1 | -3 | -5 | -6 | -5 | -3 | -4 |
| Diluted EPS | -2.77 | -1.25 | -2.91 | -5.16 | -6.39 | -4.97 | -3.35 | -4.32 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | 15.43M | 12.75M | 11.88M | 11.96M | 11.23M | 10.76M |
| Research & development | 43.64M | 42.76M | 50.48M | 45.49M | 48.55M | 56.08M |
| Operating profit | -59.07M | -55.51M | -62.35M | -57.45M | -59.78M | -66.84M |
| Pretax profit | -57.46M | -54.31M | -61.46M | -56.74M | -58.16M | -65.64M |
| Tax | -- | -- | -- | -- | -- | -- |
| Net profit | -57.46M | -54.31M | -61.46M | -56.74M | -58.16M | -65.64M |
| Basic EPS | -1 | -1 | -1 | -1 | -1 | -1 |
| Diluted EPS | -1.09 | -1.03 | -1.16 | -1.04 | -0.94 | -1.05 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 90.45M | 339.23M | 972.01M | 734.81M | 486.01M | 289.31M | 171.94M | 214.82M |
| Cash & ST investments | 88.25M | 336.48M | 968.97M | 731.51M | 478.93M | 285.51M | 168.07M | 209.86M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 92.19M | 358.87M | 1.07B | 904.22M | 666.63M | 479.37M | 335.58M | 351.53M |
| Total current liabilities | 4.83M | 11.71M | 31.42M | 64.68M | 52.50M | 41.73M | 25.57M | 45.53M |
| Short-term debt | -- | 434.00K | 2.37M | 3.93M | 9.93M | 9.77M | 10.63M | 12.06M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 5,356,000.00 | 13,507,000.00 | 206,596,000.00 | 240,900,000.00 | 230,461,000.00 | 213,591,000.00 | 185,290,000.00 | 194,150,000.00 |
| Total equity | 86.83M | 345.36M | 860.75M | 663.32M | 436.17M | 265.78M | 150.29M | 157.38M |
| Retained earnings | -110.77M | -158.13M | -291.23M | -558.22M | -892.04M | -1.15B | -1.33B | -1.56B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 142.69M | 107.92M | 75.73M | 214.82M | 175.26M | 131.36M |
| Cash & ST investments | 138.85M | 104.17M | 72.04M | 209.86M | 169.53M | 125.90M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 297.91M | 256.73M | 218.07M | 351.53M | 306.01M | 256.81M |
| Total current liabilities | 30.88M | 31.01M | 42.43M | 45.53M | 49.57M | 52.77M |
| Short-term debt | 10.95M | 11.29M | 11.75M | 12.06M | 11.66M | 9.81M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 189,067,000.00 | 186,435,000.00 | 194,377,000.00 | 194,150,000.00 | 193,905,000.00 | 195,715,000.00 |
| Total equity | 108.84M | 70.29M | 23.69M | 157.38M | 112.10M | 61.10M |
| Retained earnings | -1.39B | -1.44B | -1.50B | -1.56B | -1.62B | -1.68B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -29.03M | -39.15M | -83.43M | -182.27M | -206.46M | -154.18M | -117.32M | -136.01M |
| Depreciation & amortization | 490.00K | 911.00K | 4.21M | 8.71M | 11.00M | 25.95M | 26.71M | 26.32M |
| Free cash flow | -29.61M | -39.58M | -90.43M | -245.57M | -253.82M | -195.61M | -117.72M | -136.51M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 83.76M | 297.48M | 611.53M | -- | -- | 0 | 0 | 172.96M |
| Ending cash balance | 88.39M | 211.94M | 950.72M | 737.83M | 196.76M | 291.83M | 174.26M | 216.05M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -29.08M | -34.67M | -32.88M | -39.38M | -40.01M | -46.24M |
| Depreciation & amortization | 6.73M | 6.54M | 6.54M | 6.52M | 6.34M | 6.19M |
| Free cash flow | -29.35M | -34.81M | -32.94M | -39.42M | -40.95M | -46.59M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 145.04M | 110.35M | 78.22M | 216.05M | 175.71M | 132.09M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -458.06 | -21.92 | -22.07 | -35.04 | -60.72 | -74.22 | -84.70 | -149.49 |
| ROA %i | -86.85 | -21.00 | -18.66 | -27.08 | -42.50 | -45.46 | -43.24 | -66.94 |
| ROIC %i | -397.06 | -22.44 | -21.16 | -31.79 | -53.80 | -63.63 | -65.96 | -107.27 |
| 5-year avg ROE %i | -- | -- | -- | -- | -119.56 | -42.79 | -55.35 | -80.83 |
| EBIT margin %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 18.74 | 28.97 | 30.93 | 11.36 | 9.26 | 6.93 | 6.72 | 4.72 |
| Quick ratioi | 18.29 | 28.73 | 30.84 | 11.31 | 9.12 | 6.84 | 6.57 | 4.61 |
| Debt / assetsi | 0.00 | 0.54 | 7.25 | 8.85 | 13.16 | 17.03 | 20.96 | 16.83 |
| LT debt / equityi | -- | 0.43 | 8.72 | 11.47 | 17.84 | 27.04 | 39.74 | 29.94 |
| Interest coveragei | -6.51 | -5,919.63 | -5,322.84 | -12,134.91 | -18,544.72 | -20,036.77 | -- | -- |
| Revenue CAGR (3Y) %i | -- | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -108.92 | -140.33 | -207.92 | -149.49 | -208.80 | -368.37 |
| ROA %i | -52.04 | -60.71 | -73.58 | -66.94 | -76.39 | -94.25 |
| ROIC %i | -80.66 | -97.48 | -129.52 | -107.27 | -136.53 | -197.76 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | -- | -- | -- | -- |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 4.62 | 3.48 | 1.78 | 4.72 | 3.54 | 2.49 |
| Quick ratioi | 4.50 | 3.36 | 1.70 | 4.61 | 3.42 | 2.39 |
| Debt / assetsi | 22.70 | 25.40 | 28.52 | 16.83 | 18.30 | 20.54 |
| LT debt / equityi | 52.09 | 76.72 | 212.93 | 29.94 | 39.55 | 70.29 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Quote time 2026-10-08 08:34:35 · For reference only, not investment advice and not tailored to your situation.